Matches in Wikidata for { <http://www.wikidata.org/entity/Q83925796> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q83925796 description "artículu científicu espublizáu en mayu de 2006" @default.
- Q83925796 description "im Mai 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83925796 description "scientific article published on 26 May 2006" @default.
- Q83925796 description "wetenschappelijk artikel" @default.
- Q83925796 description "наукова стаття, опублікована в травні 2006" @default.
- Q83925796 name "Enoxaprin may be more effective than unfractionated heparin for people with high-risk non ST-segment elevation acute coronary syndromes" @default.
- Q83925796 name "Enoxaprin may be more effective than unfractionated heparin for people with high-risk non ST-segment elevation acute coronary syndromes" @default.
- Q83925796 type Item @default.
- Q83925796 label "Enoxaprin may be more effective than unfractionated heparin for people with high-risk non ST-segment elevation acute coronary syndromes" @default.
- Q83925796 label "Enoxaprin may be more effective than unfractionated heparin for people with high-risk non ST-segment elevation acute coronary syndromes" @default.
- Q83925796 prefLabel "Enoxaprin may be more effective than unfractionated heparin for people with high-risk non ST-segment elevation acute coronary syndromes" @default.
- Q83925796 prefLabel "Enoxaprin may be more effective than unfractionated heparin for people with high-risk non ST-segment elevation acute coronary syndromes" @default.
- Q83925796 P1433 Q83925796-BC5A10F0-717E-442A-8506-C205B1196B3C @default.
- Q83925796 P1476 Q83925796-BBA7762D-4FCB-4EE8-8ABC-BFE001E1DCB5 @default.
- Q83925796 P2093 Q83925796-08BFDD9F-ACCE-4829-9DA4-8E3762A567F0 @default.
- Q83925796 P2093 Q83925796-636B5A0F-B65A-452A-B42A-B7AC7C08D3A0 @default.
- Q83925796 P304 Q83925796-0B28DDC3-F996-4BBF-AE8C-C85D4A55FF6E @default.
- Q83925796 P31 Q83925796-C01B5CE2-31E2-43A4-A614-AA5EEE8E0FDF @default.
- Q83925796 P356 Q83925796-D2A80B0D-7533-4DFB-8601-34B5A2E65805 @default.
- Q83925796 P433 Q83925796-F32C2C6E-1510-4E50-8D21-ACAEF1EDD04E @default.
- Q83925796 P478 Q83925796-EAA80F47-05BD-4E1C-BC3F-2E36303FEECC @default.
- Q83925796 P577 Q83925796-6909DDA3-043D-4630-BA35-1525DE610CB8 @default.
- Q83925796 P698 Q83925796-E5F65701-00F3-40EE-BD86-59ED2409B568 @default.
- Q83925796 P921 Q83925796-BCA613BD-CD9A-4BA1-B1F7-14DCD476E78B @default.
- Q83925796 P356 J.EBCM.2006.04.019 @default.
- Q83925796 P698 16753518 @default.
- Q83925796 P1433 Q27721034 @default.
- Q83925796 P1476 "Enoxaprin may be more effective than unfractionated heparin for people with high-risk non ST-segment elevation acute coronary syndromes" @default.
- Q83925796 P2093 "Blair J O'Neill" @default.
- Q83925796 P2093 "Debbie Singh" @default.
- Q83925796 P304 "113-115" @default.
- Q83925796 P31 Q13442814 @default.
- Q83925796 P356 "10.1016/J.EBCM.2006.04.019" @default.
- Q83925796 P433 "2" @default.
- Q83925796 P478 "10" @default.
- Q83925796 P577 "2006-05-26T00:00:00Z" @default.
- Q83925796 P698 "16753518" @default.
- Q83925796 P921 Q266018 @default.